Wang Y - Search Results

1

Editorial: Tumor immune microenvironment topographies for prediction and evaluation: unlock the mystery of the therapeutic effects and adverse events of tumor immunotherapy.

Yin X, Feng Y, Zhang B, Mao X, Chen S, Wang Y, Fu SW. Yin X, et al. Among authors: wang y. Front Oncol. 2023 Nov 1;13:1301340. doi: 10.3389/fonc.2023.1301340. eCollection 2023. Front Oncol. 2023. PMID: 38023135 Free PMC article. No abstract available.

2

Effects of Surgery on Survival of Early-Stage Patients With SCLC: Propensity Score Analysis and Nomogram Construction in SEER Database.

Wang Y, Zheng Q, Jia B, An T, Zhao J, Wu M, Zhuo M, Li J, Zhong J, Chen H, Yang X, Chi Y, Dong Z, Sepesi B, Zhang J, Gay CM, Wang Z. Wang Y, et al. Among authors: wang z. Front Oncol. 2020 Apr 24;10:626. doi: 10.3389/fonc.2020.00626. eCollection 2020. Front Oncol. 2020. PMID: 32391280 Free PMC article.

3

Clinical Characteristics and Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Single-Center Experience.

Wang L, Zhao J, An T, Wang Y, Zhuo M, Wu M, Wang Z, Li J, Yang X, Chen H, Zhong J. Wang L, et al. Among authors: wang z, wang y. Front Oncol. 2020 Jul 16;10:1137. doi: 10.3389/fonc.2020.01137. eCollection 2020. Front Oncol. 2020. PMID: 32766147 Free PMC article.

4

EML4-ALK rearrangement and its clinical significance in Chinese patients with advanced non-small cell lung cancer.

Wang Z, Zhang X, Bai H, Zhao J, Zhuo M, An T, Duan J, Yang L, Wu M, Wang S, Wang Y, Wu Y, Wang J. Wang Z, et al. Among authors: wang j, wang y, wang s. Oncology. 2012;83(5):248-56. doi: 10.1159/000341381. Epub 2012 Sep 4. Oncology. 2012. PMID: 22964709

5

Analysis of EGFR mutation status in tissue and plasma for predicting response to EGFR-TKIs in advanced non-small-cell lung cancer.

Wang Y, Duan J, Chen H, Bai H, An T, Zhao J, Wang Z, Zhuo M, Wang S, Wang J. Wang Y, et al. Among authors: wang z, wang j, wang s. Oncol Lett. 2017 Apr;13(4):2425-2431. doi: 10.3892/ol.2017.5740. Epub 2017 Feb 14. Oncol Lett. 2017. PMID: 28454414 Free PMC article.

6

Efficacy and Safety of Combination Treatment With Apatinib and Osimertinib After Osimertinib Resistance in Epidermal Growth Factor Receptor-Mutant Non-small Cell Lung Carcinoma-A Retrospective Analysis of a Multicenter Clinical Study.

Yang X, Xia Y, Xu L, Liang L, Zhuo M, Wu M, An T, Wang Z, Wang Y, Li J, Zhong J, Chen H, Jia B, Wang J, Zhao J. Yang X, et al. Among authors: wang z, wang j, wang y. Front Mol Biosci. 2021 May 5;8:639892. doi: 10.3389/fmolb.2021.639892. eCollection 2021. Front Mol Biosci. 2021. PMID: 34026823 Free PMC article.

7

Significant Upregulation of HERV-K (HML-2) Transcription Levels in Human Lung Cancer and Cancer Cells.

Yang C, Guo X, Li J, Han J, Jia L, Wen HL, Sun C, Wang X, Zhang B, Li J, Chi Y, An T, Wang Y, Wang Z, Li H, Li L. Yang C, et al. Among authors: wang x, wang z, wang y. Front Microbiol. 2022 Mar 10;13:850444. doi: 10.3389/fmicb.2022.850444. eCollection 2022. Front Microbiol. 2022. PMID: 35359739 Free PMC article.

8

Rechallenge with pemetrexed-based chemotherapy improves the survival of patients with advanced non-squamous non-small-cell lung cancer.

Zhuo ML, Bai H, Wang ZJ, Duan JC, An TT, Wu MN, Zhao J, Wang YY, Wang SH, Wang J. Zhuo ML, et al. Mol Clin Oncol. 2014 Nov;2(6):953-959. doi: 10.3892/mco.2014.359. Epub 2014 Jul 24. Mol Clin Oncol. 2014. PMID: 25279180 Free PMC article.

9

Influence of chemotherapy on EGFR mutation status among patients with non-small-cell lung cancer.

Bai H, Wang Z, Chen K, Zhao J, Lee JJ, Wang S, Zhou Q, Zhuo M, Mao L, An T, Duan J, Yang L, Wu M, Liang Z, Wang Y, Kang X, Wang J. Bai H, et al. Among authors: wang z, wang j, wang y, wang s. J Clin Oncol. 2012 Sep 1;30(25):3077-83. doi: 10.1200/JCO.2011.39.3744. Epub 2012 Jul 23. J Clin Oncol. 2012. PMID: 22826274 Free PMC article.

10

A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China.

Tu HY, Feng J, Shi M, Zhao J, Wang Y, Chang J, Wang J, Cheng Y, Zhu J, Tan EH, Li K, Zhang Y, Lee V, Yang CT, Su WC, Lam DC, Srinivasa BJ, Rajappa S, Ho CL, Lam KC, Hu Y, Bondarde SA, Liu X, Tian Y, Xue Z, Cseh A, Huang DC, Zhou C, Wu YL. Tu HY, et al. Among authors: wang j, wang y. Target Oncol. 2022 Jan;17(1):1-13. doi: 10.1007/s11523-021-00859-6. Epub 2022 Jan 12. Target Oncol. 2022. PMID: 35020119 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

274,641 results

Search Page